Last reviewed · How we verify

NCT05840146

Kineesiotaping for Patients With LCPD

Completed NA Last updated 3 May 2023
What this trial tests

NA trial testing Kinesiotaping in Legg-Calve-Perthes Disease in 30 participants. Completed in 11 January 2021.

Timeline
25 September 2017
Primary endpoint
6 April 2020
11 January 2021

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment30
Start date25 September 2017
Primary completion6 April 2020
Estimated completion11 January 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 5 to 18, any sex, with Legg-Calve-Perthes Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Kinesiotaping is increasingly being used as a complement to musculoskeletal pain management. This study aimed to evaluate the immediate clinical efficacy of kinesiotaping on pain and pain-related symptoms of Legg-Calvé-Perthes Disease (LCPD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Kinesiotaping

Trials testing the same drug.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05840146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing